Search

Min Wu Phones & Addresses

  • Las Vegas, NV
  • Flushing, NY
  • Las Cruces, NM
  • Milford, MA
  • Philadelphia, PA

Work

Company: Realty 7,LLC Address: 701 E. Palisade Ave., Englewood Cliffs, NJ 07632 Phones: (201) 568-1777 (201) 724-8908

Education

School / High School: Lubin School of Business- New York, NY 2009 Specialities: Masters in Financial Management

Skills

Financial Modeling • Valuation • Data Management • Equity Analysis

Ranks

Licence: New York - Currently registered Date: 2007

Specialities

Buyer's Agent • Listing Agent

Professional Records

Lawyers & Attorneys

Min Wu Photo 1

Min Wu - Lawyer

View page
Address:
Greatway Advisory
(213) 307-0001 (Office)
Licenses:
New York - Currently registered 2007
Education:
American University, Washington College of Law

Medicine Doctors

Min Wu Photo 2

Min H. Wu

View page
Specialties:
Family Medicine
Work:
Turlock Urgent Care
2010 Colorado Ave, Turlock, CA 95382
(209) 667-1718 (phone), (209) 667-1719 (fax)
Education:
Medical School
Ross Univ, Sch of Med, Roseau, Dominica
Graduated: 2002
Procedures:
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Vaccine Administration
Wound Care
Conditions:
Acute Bronchitis
Acute Conjunctivitis
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Languages:
Chinese
English
Spanish
Description:
Dr. Wu graduated from the Ross Univ, Sch of Med, Roseau, Dominica in 2002. He works in Turlock, CA and specializes in Family Medicine. Dr. Wu is affiliated with Emanuel Medical Center.

Real Estate Brokers

Min Wu Photo 3

Min Wu, Englewood Cliffs NJ

View page
Specialties:
Buyer's Agent
Listing Agent
Work:
Realty 7,LLC
701 E. Palisade Ave., Englewood Cliffs, NJ 07632
(201) 568-1777 (Office), (201) 724-8908 (Cell)

Public records

Vehicle Records

Min Wu

View page
Address:
13720 45 Ave APT 4Y, Flushing, NY 11355
Phone:
(347) 732-1778
VIN:
2HNYD2H21BH545688
Make:
ACURA
Model:
MDX
Year:
2011

Min Wu

View page
Address:
3579 Arville St UNIT 502B, Las Vegas, NV 89103
VIN:
4T1CE30P97U758723
Make:
TOYOTA
Model:
CAMRY SOLARA
Year:
2007

Resumes

Resumes

Min Wu Photo 4

Min Wu

View page
Min Wu Photo 5

Min Wu

View page
Location:
Jackson Heights, NY
Min Wu Photo 6

Min Wu

View page
Min Wu Photo 7

Consultant At Volt

View page
Position:
Consultant at Volt
Location:
Greater New York City Area
Industry:
Financial Services
Work:
Volt
Consultant
Education:
University of Illinois at Urbana-Champaign - College of Business
Min Wu Photo 8

Min Wu

View page
Location:
United States
Min Wu Photo 9

Min Wu

View page
Location:
United States
Min Wu Photo 10

Min Wu

View page
Location:
United States
Min Wu Photo 11

Min Wu New York, NY

View page
Work:
dealReporter Financial Times

Jan 2011 to 2000
Risk Arbitrage Analyst

Haver Analytics
New York, NY
Jul 2009 to Jan 2011
Senior Research Associate

Industrial Bank Co., Ltd. - China
Tianjian
Aug 2007 to Jul 2008
Intern, Risk Management

Education:
Lubin School of Business
New York, NY
2009 to 2010
Masters in Financial Management

Tianjin University of Finance and Economics - China
2003 to 2007
BS in Accounting

Skills:
Financial Modeling, Valuation, Data Management, Equity Analysis

Business Records

Name / Title
Company / Classification
Phones & Addresses
Min Wu
Senior Scientist
Aveo Pharmaceuticals, Inc.
Commercial Physical and Biological Research
75 Sidney St Fl 4, Cambridge, MA 02139
Min Wu
Owner
A F Sona Corp
Eating Place
414 Ditmas Ave, Brooklyn, NY 11218
Min Wu
Principal
Dw Linden Supply Inc
Whol Durable Goods
332 Linden St, Brooklyn, NY 11237
Min Wu
Senior Scientist
Aveo Pharmaceuticals, Inc
Mfg Pharmaceutical Preparations · Pharmaceutical Preparations · Research & Development in Biotechnology
75 Sidney St, Cambridge, MA 02139
64 Sidney St, Cambridge, MA 02139
(617) 299-5000, (617) 995-4827, (617) 995-4995
Min Wu
SEA TOWN FISH & MEAT MARKET, INC
681 Seneca Ave, Forest Hills, NY 11375
Min Wu
Chief Executive Officer
TEIN FU RESTAURANT CORP
Eating Place
872 W Beech St, Long Beach, NY 11561
Min Wu
Real property
ASIAN MARKET, LLC
229 Tpke Rd, Westborough, MA 01581
Westborough, MA 01581
Min Wu
WW 679 SENECA CORP
681 Seneca Ave 2, Ridgewood, NY 11385
681A Seneca Ave, Ridgewood, NY 11385
Min Wu
Senior Scientist
Aveo Pharmaceuticals, Inc.
Commercial Physical and Biological Research
75 Sidney St Fl 4, Cambridge, MA 02139

Publications

Us Patents

Method Of Screening Endothelial Cells For Angiogenic Capability

View page
US Patent:
7547518, Jun 16, 2009
Filed:
Aug 6, 2004
Appl. No.:
10/913209
Inventors:
Min Wu - Carlisle MA, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G01N 33/53
G01N 33/533
G01N 33/577
C12P 21/08
C07K 16/28
US Classification:
435 71, 435 721, 435 792, 435 75, 5303871, 53038822, 5303891, 5303913
Abstract:
Provided is a method of screening a primary endothelial cell population for angiogenesis capability comprising: (a) measuring the percentage of cells that are positive for VEGF R2 and CD34, the level of VEGF R2, or measuring the VEGF R2 to VEGF R1 ratio in the population; and (b) selecting those populations where the measured percentage or the measured ratio is over a threshold value.

Modified Reconstituted Basement Membrane Composition For Assay System

View page
US Patent:
7608455, Oct 27, 2009
Filed:
Dec 13, 2004
Appl. No.:
11/010679
Inventors:
Min Wu - Carlisle MA, US
Frank J. Mannuzza - Chelmsford MA, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12N 5/00
US Classification:
435402, 435395, 435397
Abstract:
A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.

Method Of Screening Endothelial Cells For Angiogenic Capability

View page
US Patent:
8003336, Aug 23, 2011
Filed:
May 8, 2009
Appl. No.:
12/463010
Inventors:
Min Wu - Carlisle MA, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G01N 33/53
G01N 33/541
C07K 16/28
US Classification:
435 71, 435 721, 435 75, 435 792, 5303871, 53038822, 5303913
Abstract:
Provided is a method of screening a primary endothelial cell population for angiogenesis capability comprising: (a) measuring the percentage of cells that are positive for VEGF R2 and CD34, the level of VEGF R2, or measuring the VEGF R2 to VEGF R1 ratio in the population; and (b) selecting those populations where the measured percentage or the measured ratio is over a threshold value.

System To Label Plates

View page
US Patent:
8371051, Feb 12, 2013
Filed:
Aug 19, 2004
Appl. No.:
10/922559
Inventors:
Min Wu - Carlisle MA, US
Assignee:
Corning Incorporated - Corning NY
International Classification:
G09F 3/00
US Classification:
40324
Abstract:
A label for a multi-well plate is provided including a visually observable indicia in a predetermined position on at least an upper side of a portion of the multi-well plate. The indicia has a color in contrast to the multi-well plate and is substantially permanently affixed to at least the upper side of the plate. A method for orienting plates using the label and a system of labeling are also provided.

Reconstituted Human Breast Tumor Model

View page
US Patent:
8373017, Feb 12, 2013
Filed:
Dec 6, 2005
Appl. No.:
11/296241
Inventors:
Min Wu - Winchester MA, US
Charlotte Kuperwasser - Boston MA, US
Murray Robinson - Boston MA, US
Assignee:
AVEO Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A01K 67/00
A01K 67/027
US Classification:
800 10, 800 13, 800 14, 800 18
Abstract:
Reconstituted human breast tumor models are disclosed. The models, which are incorporated into mice, provide actual tumors that arise spontaneously, thereby mimicking naturally occurring breast cancer. The tumors are genetically human, because they arise from human mammary tissues that develop from human mammary epithelial cells implanted into host mice. Prior to implantation, the mammary epithelial cells are genetically modified to contain either: (a) a recombinant human oncogene and an SV40er; or (b) a recombinant human oncogene, a transgene or shRNA that inhibits the p53 pathway, and a transgene or shRNA that inhibits the Rb pathway.

Modified Reconstituted Basement Membrane Composition For Assay System

View page
US Patent:
8541235, Sep 24, 2013
Filed:
Sep 28, 2009
Appl. No.:
12/567996
Inventors:
Min Wu - Carlisle MA, US
Frank J. Mannuzza - Chelmsford MA, US
Assignee:
Corning Incorporated - Corning NY
International Classification:
C12N 5/00
US Classification:
435402, 435397, 435395
Abstract:
A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.

Modified Reconstituted Basement Membrane Composition For Assay System

View page
US Patent:
20050079611, Apr 14, 2005
Filed:
Aug 2, 2004
Appl. No.:
10/909636
Inventors:
Min Wu - Carlisle MA, US
Frank Mannuzza - Chelmsford MA, US
International Classification:
C12N005/02
US Classification:
435404000, 424426000
Abstract:
A modified reconstituted extracellular matrix composition is provided herein. The composition includes an extracellular matrix and at least one exogenous component selected from heparin, fibronectin and laminin. The composition may have a basic pH. Additionally, provided herein is a cell culturing system including a substrate and a coating thereon of the composition to assess potential stimulators and/or inhibitors for their effects on various cell cultures while increasing the signal dynamic range.

Reconstituted Human Breast Tumor Model

View page
US Patent:
20060123493, Jun 8, 2006
Filed:
Dec 7, 2004
Appl. No.:
11/006413
Inventors:
Min Wu - Winchester MA, US
Charlotte Kuperwasser - Boston MA, US
Murray Robinson - Boston MA, US
International Classification:
A01K 67/027
US Classification:
800011000, 800018000
Abstract:
A reconstituted human breast tumor model is disclosed. The model, which is incorporated into mice, provides actual tumors that arise spontaneously, thereby mimicking naturally occurring breast cancer. The tumors are genetically human, because they arise from human mammary tissues that develop from human mammary epithelial cells implanted into host mice. Prior to implantation, the mammary epithelial cells are genetically modified to contain a recombinant human oncogene and an SV40 early region.

Isbn (Books And Publications)

Multimedia Data Hiding

View page
Author

Min Wu

ISBN #

0387954260

Min Shing Wu from Las Vegas, NV, age ~60 Get Report